Emerald Clinical Trials

Emerald Clinical Trials is a clinical research organization (CRO) offering end-to-end trial services: clinical trial management, regulatory consulting, medical writing, data management and biostatistics, and safety and pharmacovigilance. Its website says it covers early-phase and late-phase studies, with particular focus on renal, oncology and cardiometabolic research.

The website describes its customers as biopharmaceutical, medical device and diagnostic companies. The business is a service provider that runs studies for sponsors, and the website does not describe its pricing or revenue model in detail.

The company traces its origins to The George Institute, established in Australia in 1999; George Clinical was set up as a separate CRO in 2008 and rebranded as Emerald Clinical in 2025. The website states it is headquartered in Singapore, operates in 40+ locations, and has 800+ people. Its open job listings cover clinical operations, data science and biostatistics, project management, medical writing and drug safety, across locations including China, Taiwan, Malaysia, India, Australia, the United States and Europe.

Product: Full-service clinical trial management, regulatory consulting, medical writing, data management, biostatistics and safety/pharmacovigilance services.